COSMO TECHNOLOGIES LTD FDA Approval NDA 212295

NDA 212295

COSMO TECHNOLOGIES LTD

FDA Drug Application

Application #212295

Documents

Label2020-07-02
Letter2020-07-06
Review2020-07-31
Letter2020-12-01
Label2020-12-01
Letter2021-04-09
Label2021-04-12
Federal Register Notice2021-10-08
Label2023-01-17

Application Sponsors

NDA 212295COSMO TECHNOLOGIES LTD

Marketing Status

Prescription001

Application Products

001INJECTABLE;INJECTION20MG2BYFAVOREMIMAZOLAM

FDA Submissions

TYPE 1/4; Type 1 - New Molecular Entity and Type 4 - New CombinationORIG1AP2020-07-02STANDARD
LABELING; LabelingSUPPL2AP2021-04-08STANDARD
LABELING; LabelingSUPPL3AP2023-01-13STANDARD

Submissions Property Types

ORIG1Null7
SUPPL2Null6
SUPPL3Null6

CDER Filings

COSMO TECHNOLOGIES LTD
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 212295
            [companyName] => COSMO TECHNOLOGIES LTD
            [docInserts] => ["",""]
            [products] => [{"drugName":"BYFAVO","activeIngredients":"REMIMAZOLAM","strength":"20MG","dosageForm":"INJECTABLE;INJECTION","marketingStatus":"Prescription","te":"None","rld":"TBD","rs":"No"}]
            [labels] => [{"actionDate":"07\/02\/2020","submission":"ORIG-1","supplementCategories":"Approval","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2020\\\/212295s000lbl.pdf\"}]","notes":""}]
            [originalApprovals] => [{"actionDate":"07\/02\/2020","submission":"ORIG-1","actionType":"Approval","submissionClassification":"Type 1 - New Molecular Entity and Type 4 - New Combination","reviewPriority":"STANDARD","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2020\\\/212295s000lbl.pdf\"},{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2020\\\/212295Orig1s000ltr.pdf\"}]","notes":">"}]
            [supplements] => 
            [actionDate] => 2020-07-02
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.